QLF31907 not checked

Qilu Pharmaceutical

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
3 in total
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Advanced Malignant Neoplasm
Main trialPhase 1/2
“This study is designed to evaluate the safety and efficacy of QLF31907 combination therapy in advanced malignant tumors.”In the company’s words, NCT06394713 on ClinicalTrials.gov

Other drugs for Advanced Malignant Neoplasm

All 560 drugs for Advanced Malignant Neoplasm

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 1/2Not yet recruiting 15 Jun 2025 A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors
Phase 2Unknown Oct 2023 Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma
Phase 1Unknown 31 Mar 2024 A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow QLF31907

Following is part of Solo: you see every change to QLF31907 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in